Dr Nicola Kalk
Clinical Lead
Biography
Dr Nicola Kalk is a Visiting Senior Lecturer in the Department of Addictions at the Institute of Psychiatry, Psychology & Neuroscience, and a Consultant Addiction Psychiatrist working in the Kings College Hospital Addictions Care Team for the South London & Maudsley NHS Foundation Trust.
She is a co-investigator on the D-SITAR study (NIHR205228) evaluating the implementation of the ten year drug strategy and ProACTIVE study (NIHR152084) evaluating Alcohol Care Teams. She is involved in the National Programme on Substance Use Mortality that collates reports from coroners in England, Wales, and Northern Ireland pertaining to deaths related to psychoactive drug use.
Dr Kalk received her MBChB from the University of Cape Town. After receiving the Rhodes Scholarship, she completed an MSc in Social Policy and an MSc in Neuroscience at the University of Oxford. Dr Kalk's PhD was in Addiction Psychiatry, completed at Imperial College London funded by a Wellcome Trust GSK Tranlsational Training Fellowship.
Research
The National Programme on Substance Use Mortality (NPSUM)
The NPSUM enables analysis of trends in deaths due to illicit substances or licensed medications to inform harm reduction strategy and increase patient safety.
Project status: Ongoing
News
Over £5m in NIHR funding for three addictions research projects harnessing AI and wearable technology
The three projects - Prison Release Engagement Trial, the use of virtual reality enhanced cue exposure treatment in people with cocaine dependence, and...
Teens with problematic smartphone use are twice as likely to have anxiety – and many are eager to cut down
Two new studies of smartphone habits in teenagers have identified links between problematic smartphone use (PSU) and depression, anxiety and insomnia. The...
Features
Humanising Healthcare podcast - "‘Synthetic opioids claiming lives"
Manasi is joined by Dr Caroline Copeland, Senior Lecturer in Pharmacology & Toxicology and Dr Nicola Kalk, Visiting Clinical Lecturer.
Research
The National Programme on Substance Use Mortality (NPSUM)
The NPSUM enables analysis of trends in deaths due to illicit substances or licensed medications to inform harm reduction strategy and increase patient safety.
Project status: Ongoing
News
Over £5m in NIHR funding for three addictions research projects harnessing AI and wearable technology
The three projects - Prison Release Engagement Trial, the use of virtual reality enhanced cue exposure treatment in people with cocaine dependence, and...
Teens with problematic smartphone use are twice as likely to have anxiety – and many are eager to cut down
Two new studies of smartphone habits in teenagers have identified links between problematic smartphone use (PSU) and depression, anxiety and insomnia. The...
Features
Humanising Healthcare podcast - "‘Synthetic opioids claiming lives"
Manasi is joined by Dr Caroline Copeland, Senior Lecturer in Pharmacology & Toxicology and Dr Nicola Kalk, Visiting Clinical Lecturer.